Literature DB >> 12176567

Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition.

Barbara Suwelack1, M Kempkes-Koch, V Kobelt, U Hillebrand, F Matzkies, U Gerhardt, H Hohage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176567     DOI： 10.1016/s0041-1345(02)03058-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Pharmacogenetics of cardiovascular drug therapy.

Authors:  Bas J M Peters; Olaf H Klungel; Anthonius de Boer; Bruno H Ch Stricker; Anke-Hilse Maitland-van der Zee
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 2.  Antihypertensive treatment for kidney transplant recipients.

Authors:  Nicholas B Cross; Angela C Webster; Philip Masson; Philip J O'Connell; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

3.  Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.

Authors:  Madlaina Scharplatz; Milo A Puhan; Johann Steurer; Annalisa Perna; Lucas M Bachmann
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-10-24

4.  ACE genotype, risk and causal relationship to stroke: implications for treatment.

Authors:  Agnieszka Slowik; Tomasz Dziedzic; Joanna Pera; Dorota Wloch; Grzegorz Kopec; Andrzej Szczudlik
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06

5.  What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review.

Authors:  M Scharplatz; M A Puhan; J Steurer; L M Bachmann
Journal:  BMC Med Genet       Date:  2004-09-10       Impact factor: 2.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.